Lunch brief: Revolutionizing bioavailability: The LiposoMax™ delivery technology advantage (One Innovation Labs)

Lunch brief: Revolutionizing bioavailability: The LiposoMax™ delivery technology advantage (One Innovation Labs)

Thursday, October 31, 2024 12:00 PM to 1:00 PM · 1 hr. (America/Los_Angeles)
Lower Level, South Pacific Ballroom A
Breakfast and lunch briefs
Sponsored

Information

Using a pioneering, proprietary process, LiposoMax™ from One Innovation Labs is an advanced ingredient delivery technology merging active compounds with natural phospholipids and lipid metabolites. This unique formulation boasts exceptional bioavailability due to its unparalleled composition. It both preserves and enhances the stability of liposomal ingredients, setting new standards for ensuring greater efficacy and boosting long-term stability for liposomal delivery systems.

Committed to scientific excellence, One Innovation Labs integrates cutting-edge technologies to augment absorption, receptor binding and pharmacokinetic profiles. LiposoMax finds application across diverse sectors including supplements, foods, beverages, cosmetics and pharmaceuticals.

Attendees will learn:

  • Benefits of liposomal delivery
  • The unique advantages of LiposoMax
  • Scientific rigor and trusted excellence
  • Diverse application benefits

Speakers:

  • Pedro P. Perez, Ph.D. chief scientific officer, One Innovation Labs
  • Benjamin S. Weeks, Ph.D. professor, College of Arts & Sciences, Adelphi University
  • Zain M. Saiyed, Ph.D., FACN, director, R&D DFS and product development, Lonza

This brief is an invite-only event. If you are interested in attending, please reach out to Shilo Lusson at shilo.lusson.us@informa.com.